Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development

M Schlitzer - ChemMedChem: Chemistry Enabling Drug …, 2007 - Wiley Online Library
Since ancient times, humankind has had to struggle against the persistent onslaught of
pathogenic microorganisms. Nowadays, malaria is still the most important infectious disease …

The past, present and future of antifolates in the treatment of Plasmodium falciparum infection

A Nzila - Journal of Antimicrobial Chemotherapy, 2006 - academic.oup.com
Chemotherapy remains the most important means of controlling malaria, one of the
deadliest infectious parasitic diseases in the world. Antimalarial antifolates have been …

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

Y Yuthavong, B Tarnchompoo… - Proceedings of the …, 2012 - National Acad Sciences
Malarial dihydrofolate reductase (DHFR) is the target of antifolate antimalarial drugs such as
pyrimethamine and cycloguanil, the clinical efficacy of which have been compromised by …

DNA and RNA synthesis: antifolates

IM Kompis, K Islam, RL Then - Chemical reviews, 2005 - ACS Publications
Tetrahydrofolate cofactors are essential for the synthesis of purines, certain amino acids,
and thymidine. Most bacteria and plants produce these folate cofactors by de novo …

Triazine as a promising scaffold for its versatile biological behavior

P Singla, V Luxami, K Paul - European journal of medicinal chemistry, 2015 - Elsevier
Among all heterocycles, the triazine scaffold occupies a prominent position, possessing a
broad range of biological activities. Triazine is found in many potent biologically active …

Purine and pyrimidine pathways as targets in Plasmodium falciparum

M Belen Cassera, Y Zhang… - Current topics in …, 2011 - ingentaconnect.com
Malaria is a leading cause of morbidity and mortality in the tropics. Chemotherapeutic and
vector control strategies have been applied for more than a century but have not been …

The state of the art in anti-malarial drug discovery and development

J N. Burrows, K Chibale… - Current topics in medicinal …, 2011 - benthamdirect.com
Malaria is one of the most prevalent and devastating infectious diseases of our time. Yet,
unfortunately, apart from artemisinin combination therapies there are relatively few effective …

Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature

R Kaur, P Kaur, S Sharma, G Singh… - Recent patents on …, 2015 - ingentaconnect.com
Pyrimidine ring is the building unit of DNA and RNA and thus pyrimidine based chemical
architectures exhibit diverse pharmacological activities. Among the reported medicinal …

Discovery of potential HER2 inhibitors from Mangifera indica for the treatment of HER2-Positive breast cancer: an integrated computational approach

TA Balogun, MN Iqbal, OA Saibu… - Journal of …, 2022 - Taylor & Francis
Human epidermal growth factor receptor 2 (HER2) is a member of epidermal growth factor
receptors with tyrosine kinase functionality. The dimerization of HER2 leads to the …

Targeting DHFR in parasitic protozoa

AC Anderson - Drug Discovery Today, 2005 - Elsevier
Parasitic apicomplexans are responsible for some of the most severe worldwide health
problems, including malaria, toxoplasmosis and cryptosporidiosis. These parasites are …